|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
SCAI Issues Multisocietal Overview Document on LAA
SCAI, ACC and HRS released a new overview document on the implantation of left atrial appendage (LAA) occlusion June 29, the first in a series of clinical documents that will address the integration of new technologies into the care of patients with atrial fibrillation. This document highlights the critical issues surrounding LAA occlusion, including the collection of the necessary data in longitudinal registries to determine ideal patient selection, effectiveness and safety as well as the development and implementation of new guidelines, expert consensus statements, requirements for training, operator credentialing and institutional policies.
Find out more about this new clinical document.
SCAI SHD Committee Chair Cliff Kavinsky, MD, PhD, FSCAI, discusses this new document
Related: Download the latest SCAI clinical documents and resources
ACC/HRS/SCAI Seek to Unify Rollout of Percutaneous LAA Occlusion (Cardiology News)
Societies Issue Recommendations for Left Atrial Appendage Occlusion (SCAI)
Societies Release Recommendations for Implantation of Percutaneous LAA Occlusion Devices (Healio)
| Share this article:
Whether you are a healthcare professional, a patient or simply someone looking to know more about the complete solutions offered by Cordis, let us show you how our distinctive approach to working in partnership with you results in innovative interventional products and services to help support sustained patient outcomes.
SCAI TAVR Center Journal Scan Now Online
With developments surrounding TAVR moving so quickly, those seeking to be "in the know" are turning to SCAI's TAVR Center, and you should be too. Bookmark it now: www.SCAI.org/TAVRCenter.
Features include the latest news on Food and Drug Administration approvals and developments, as well as research in the field, image reviews and quarterly poll questions. A monthly feature is the TAVR Journal Scan, a compilation of the past month's most relevant TAVR-related publications from the journals across the cardiology field. Read the June Journal Scan now, including the top article from European Heart Journal, "A prospective randomized evaluation of the TriGuard™ HDH embolic DEFLECTion device during transcatheter aortic valve implantation: Results from the DEFLECT III trial."
Been busy? Catch up with the June TAVR Center Journal Scan.
Have a great TAVR or structural heart disease case to share?
Related: Participate in our new TAVR Center Summer Poll in which we ask, "With the introduction of the Corevalve Evolut R and the Sapien 3, who do you believe TAVR should be offered to?"
The SCAI TAVR Center is supported through an educational grant from platinum sponsor Medtronic. The Society gratefully acknowledges this support while taking sole responsibility for all content developed and disseminated through this effort.
GLIDESHEATH SLENDER® 5Fr and 7Fr!
The only family of unique thin-wall sheaths, offering radial access to more patients.
• Increase Your Radial Access Options
• Optimize Procedural Outcomes
• Preserve Arterial Function
*GLIDESHEATH SLENDER® is currently available in 6Fr.
©2015 Terumo Medical Corporation. All rights reserved.
All brand names are trademarks or registered trademarks of Terumo. TIS-694-06012015
Image of the Week: Symptomatic Carotid String Sign
Kamal Gupta, MD, FSCAI, Karthik Vamanan, MD, RVT, and cardiology fellow Andrew Waters, MD, of University of Kansas Medical Center, present a case a 71-year-old man with a history of repaired AAA presenting to the emergency department with repeated but transient episodes of sudden left upper extremity weakness and numbness, slurring of speech, BP of 140/90 mmHg and HR of 75/min. The patient was on ASA 81 mg, clopidogrel 75 mg, atorvastatin 40 mg and lisinopril 20 mg. A CT angiography and carotid angiogram were obtained. Find out what these revealed and weigh in on what your next step would be.
State-of-the-Art PVD Education Designed for Your Real-World Practice
Advances in peripheral interventions are moving at the speed of light and the number of complex PVD patients is rapidly growing. However, present guidelines and data do not adequately inform thoughtful clinicians how to provide the best care for their patients.
The solution? SCAI has developed the Complex Peripheral Interventions Workshop (SCAI CPVI) to help you incorporate state-of-the-art peripheral interventions into your "real-world" practice using a novel, interactive education approach focused on how you learn best.
More information, including agenda and registration
Case-based, intensive focus on aorto-iliac intervention, SFA intervention and critical limb ischemia
- Review of real cases starting weeks before the workshop
- Small groups coming together to discuss, solve and present cases — bring yours!
- Simulator training opportunities to try new techniques
- Focus on latest data and guidelines from those who produced them
- Fun: This program will be interactive, social and unlike any other you've attended
SCAI gratefully acknowledges the following companies for their generous support of the SCAI Complex Peripheral Interventions course through educational grants while taking sole responsibility for all content developed and disseminated through this event.
- Silver sponsors: Medtronic, Terumo Interventional Systems
- Bronze sponsors: Abbott; AstraZeneca
Looking for a Resource to Encourage DAPT Adherence?
SCAI's public education website, SecondsCount.org, features You & Your Stent, an unbranded video developed to help patients and their families understand how the heart and arteries work, how arteries can become blocked and how angioplasty restores blood flow to the heart. Your patients can learn how to take care of their stent, including medication adherence and lifestyle changes.
Watch You & Your Stent in English or Spanish.
You & Your Stent is provided compliments of Daiichi Sankyo/Eli Lilly in partnership with SCAI. Copyright 2013 Daiichi Sankyo, Inc. and Lilly USA LLC. All Rights Reserved.
SCAI-ELM Fellow Blogs on 'The Dilemma of Hard Cases and Patient-Centeredness'
In the latest Eye on Intervention blog, SCAI-ELM Fellow Farouc A. Jaffer, MD, PhD, FSCAI, tackles questions about how the interventional cardiology community can work together to ensure that underserved patients — those whose lesions make them high-risk or hard-to-treat — receive the care they need.
Read and comment on Dr. Jaffer's blog.
CMS Will Modify — Not Scrap — 'Two-Midnight' Rule
The Centers for Medicare and Medicaid Services plans to soften but keep the controversial "two-midnight" rule governing short hospital stays in spite of aggressive calls from providers and policy experts to abandon the policy.
In a proposed payment rule, the Obama administration said it plans to allow physicians to exercise judgment to admit patients for short hospital stays on a case-by-case basis.
Updated Stroke Guidelines Back the Use of Stent Retrievers in Select Patients
A new recommendation favoring stent retrievers after IV fibrinolysis to treat ischemic stroke in well-defined settings is the centerpiece of a focused update of the 2013 American Heart Association/American Stroke Association acute stroke guidelines, which were published online June 29 ahead of print in Stroke. An expert task force analyzed eight randomized clinical trials of endovascular treatment and other relevant data published since 2013, zeroing in on what it called "pivotal new evidence" that warrants changes in current guidelines.
Related: Guideline Update Recommends Stent-retrieval Devices to Treat Certain Patients With Stroke (Healio)
New Guidelines Suggest Use of Clot-grabbing Device in Some Strokes (The Washington Post)
New AHA/ASA Guideline Recommends Endovascular Stroke Therapy (Medscape)
American Heart Association's New Stroke Treatment Guidelines Establish Stent Retrievers as First-line Endovascular Treatment for Acute Ischemic Stroke
Societies Release Recommendations for Implantation of Percutaneous LAA Occlusion Devices
Percutaneous left atrial appendage occlusion devices are intended to reduce risk for stroke in patients with atrial fibrillation who are unable or unwilling to adhere to long-term anticoagulation therapy, and the use of these devices is likely to expand. According to a new statement, this technology should be disseminated thoughtfully, with emphasis on team-based care and the collection of data in longitudinal registries.
The American College of Cardiology, Heart Rhythm Society and Society for Cardiovascular Angiography and Interventions released an overview on left atrial appendage occlusion, with recommendations on implantation, operator training, protocols for care and patient selection.
Related: ACC/HRS/SCAI Seek to Unify Rollout of Percutaneous LAA Occlusion (Cardiology News)
Societies Issue Recommendations for Left Atrial Appendage Occlusion (SCAI)
LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease
Using a paclitaxel-coated balloon to treat femoropopliteal artery disease results in better primary patency than does standard balloon angioplasty at one year and is associated with good safety outcomes, according to a study published online June 24 ahead of print in the New England Journal of Medicine. In October 2014, Lutonix 035 became the first drug-coated balloon to be approved by the Food and Drug Administration for the indication of femoropopliteal artery disease.
Op-ed: Take a Stand on Cath Lab Health Hazards
As written by Lloyd W. Klein, MD, FSCAI, "Interventional cardiologists take our responsibility to improve patient quality of life and increase the likelihood of survival in heart diseases seriously, and we are willing to accept personal risk to practice our profession. Perhaps this is why, for the past 30 years or so, interventionalists never made a fuss about the health problems we face as a result of our work in fluoroscopy labs."
CTOs Relatively Frequent in Patients Without Previously Known CAD
Chronic total occlusions are "not uncommon" in patients undergoing coronary computed tomography angiography for suspected CAD, according to a registry study published online June 15 ahead of print in Heart.
For a complete list of job postings, click here.
To post your resume, click here.
||SCAI Fellows Course at LWSIC
||SCAI TAVR Session @ SOLACI
||Mexico City, MEXICO
||SCAI China Fellows Course
||SCAI CPVI - Complex Peripheral Vascular Interventions
SCAI at Great Wall International Congress of Cardiology
SCAI Fellows Course at AICT 2015
||SCAI 2015 Fall Fellows Courses
||SCAI Session at CardioEgypt 2016
|May 4-7, 2016
||SCAI 2016 Scientific Sessions
CLICK HERE for a full calendar of SCAI events
The news summaries appearing in SCAI This Week are based on original information from news organizations and are produced by Multibriefs, an independent e-mail newsletter publisher. SCAI is not responsible for the content of sites external to SCAI, nor do reports in SCAI This Week constitute the official opinion of SCAI.
The SCAI This Week news roundup is provided as a timely update for SCAI members and other healthcare professionals. Links to articles are provided for readers' convenience and may be of use in discussions with patients or colleagues. Questions and comments about SCAI This Week may be directed to Multibriefs at firstname.lastname@example.org.
Missed last week's issue? See which articles your colleagues read most.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063